In MM tumour-bearing NSG mice treated with GSI, BCMA expression on malignant cells was upregulated, soluble BCMA fragments in peripheral blood were reduced, and the efficacy of BCMA-targeted CAR-T cells was significantly enhanced [150]. The gene discussed is TNFRSF17; the disease is neoplasm.